GURUFOCUS.COM » STOCK LIST » Technology » Software » Core Scientific Inc (OTCPK:CORZQ) » Definitions » Long-Term Debt & Capital Lease Obligation

Core Scientific (Core Scientific) Long-Term Debt & Capital Lease Obligation : $626.8 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Core Scientific Long-Term Debt & Capital Lease Obligation?

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Core Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $626.8 Mil.

Warning Sign:

Core Scientific Inc keeps issuing new debt. Over the past 3 years, it issued USD 668.999 million of debt.

LT-Debt-to-Total-Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligation divides by its Total Assets. Core Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $626.8 Mil. Core Scientific's Total Assets for the quarter that ended in Mar. 2024 was $814.0 Mil. Core Scientific's LT-Debt-to-Total-Asset for the quarter that ended in Mar. 2024 was 0.77.

Core Scientific's LT-Debt-to-Total-Asset increased from Mar. 2023 (0.00) to Mar. 2024 (0.77). It may suggest that Core Scientific is progressively becoming more dependent on debt to grow their business.


Core Scientific Long-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Core Scientific's Long-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Scientific Long-Term Debt & Capital Lease Obligation Chart

Core Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt & Capital Lease Obligation
5.28 22.13 714.36 0.72 721.34

Core Scientific Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 1.08 716.52 721.34 626.77

Core Scientific Long-Term Debt & Capital Lease Obligation Calculation

Long-Term Debt is the debt due more than 12 months in the future. The debt can be owed to banks or bondholders. Some companies issue bonds to investors and pay interest on the bonds.

Long-Term Capital Lease Obligation represents the total liability for long-term leases lasting over one year. It's amount equal to the present value (the principal) at the beginning of the lease term less lease payments during the lease term.

The interest paid on companies' debt is reflected in the income statement as interest expense. If a company has too much debt and it cannot serve the interest payment on the debt or repay the matured debt, the company risks bankruptcy. Peter Lynch famously said: A company that does not have debt cannot go bankrupt.

A company's long term debt may have different dates of maturity and interest rates, depending on the terms.

Usually a company issues long term debt to pay for its capital expenditures. Borrowing allows the company to do things that otherwise cannot be done with only the capital it has. But debt can be risky.


Core Scientific  (OTCPK:CORZQ) Long-Term Debt & Capital Lease Obligation Explanation

LT-Debt-to-Total-Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Core Scientific's LT-Debt-to-Total-Asset ratio for the quarter that ended in Mar. 2024 is calculated as:

LT-Debt-to-Total-Asset (Q: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )/Total Assets (Q: Mar. 2024 )
=626.765/813.968
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Buffett says that durable competitive advantages carry little to no long-term debt because the company is so profitable that even expansions or acquisitions are self financed.

We are interested in long term debt load for the last ten years. If the ten years of operation show little to no long term debt, then the company has some kind of strong competitive advantage.

Warren Buffett's historic purchases indicate that on any given year, the company should have sufficient yearly net earnings to pay all long term within 3 or 4 year earnings period. (e.g. Coke + Moody's = 1yr)

Companies with enough earning power to pay long term debt in less than 3 or 4 years is a good candidate in our search for long term competitive advantage.

BUT, these companies are targets for leveraged buy outs, which saddles the business with long term debt.

If all else indicates the company has a moat, but it has ton of debt, a leveraged buyout may have created the debt. In these cases the company's bonds offer the better bet, in that the company’s earnings power is focused on paying off the debt and not growth.

Important: little or no long term debt often means a Good Long Term Bet


Core Scientific Long-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Core Scientific's Long-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Scientific (Core Scientific) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Software » Core Scientific Inc (OTCPK:CORZQ) » Definitions » Long-Term Debt & Capital Lease Obligation
Traded in Other Exchanges
Address
210 Barton Springs Road, Austin, TX, USA, 78704
Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.
Executives
Adam Taylor Sullivan officer: President C/O CORE SCIENTIFIC, INC., 2407 S. CONGRESS AVENUE, AUSTIN TX 78704
Darin Feinstein director, 10 percent owner, officer: Chief Vision Officer 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Sterling Denise Marie Brucia officer: Chief Financial Officer C/O CORE SCIENTIFIC, INC., 201 BARTON SPRINGS ROAD, AUSTIN TX 78704
Matt Minnis director 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Brian Neville officer: Chief Accounting Officer C/O CORE SCIENTIFIC, INC., 2800 NORTHROP WAY, BELLEVUE WA 98004
Todd M Duchene officer: EVP, GC and Secretary 847 GIBRALTAR DR., MILPITAS CA 95035
Michael Trzupek officer: Chief Financial Officer 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Stacie Olivares director 2525 E. CAMELBACK RD., STE 850, PHOENIX AZ 85016
Jarvis V. Hollingsworth director 100 WEST HOUSTON STREET, SAN ANTONIO TX 78205
Michael J Levitt director, officer: Chief Executive Officer KAYNE ANDERSON CAPITAL ADVISORS, L.P., 1800 AVENUE OF THE STARS, 3RD FLOOR, LOS ANGELES CA 90067
Dr Kneeland Youngblood director C/O GAP, INC., 2 FOLSOM ST., SAN FRANCISCO CA 94105
John P Mcgarrity officer: General Counsel and Secretary 321 N. CLARK STREET, CHICAGO IL 60054
Sullivan Colleen director 420 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA 92037
Theodore J Brombach 10 percent owner 321 N. CLARK STREET, CHICAGO IL 60054
Patrick C Eilers director, 10 percent owner, officer: Chief Executive Officer THREE FIRST NATIONAL PLAZA STE 3800, CHICAGO IL 60602

Core Scientific (Core Scientific) Headlines

From GuruFocus